XML 85 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of Contingent Consideration

A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the year ended December 31, 2019 and 2018 is as follows (in thousands):

Year Ended December 31, 2019		Contingent Consideration Liability Related to Acquisition of Arkis (See Note 4)				Contingent Consideration Liability Related to Acquisition of Derma Sciences (See Note 4)			Location in Financial Statements
		Long-term				Long-term
Balance as of January 1, 2019		$	—			$	230
Additions from acquisition of Arkis		13,100				—
Payments		—				—
Loss from change in fair value of contingent consideration liabilities		1,110				—			Research and development
Balance as of December 31, 2019		$	14,210			$	230

Year Ended December, 2018		Contingent Consideration Liabilities Related to Acquisition of Derma Sciences (See Note 4)								Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.			Location in Financial Statements
		Short-term				Long-term				Short-term
Balance as of January 1, 2018		$	315			$	1,387			$	22,478
Transfers from long-term to current portion		1,387				(1,387		)		—
Payments		(2,000		)		—				(24,000		)
Loss from change in fair value of contingent consideration liabilities		298				230				1,522			Selling, general and administrative
Balance as of December 31, 2018		$	—			$	230			$	—

X

- References

No definition available.

+ Details

Name:	us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration